补中消饮对胶原诱导性关节炎大鼠lncRNA与mRNA的交叉分析及潜在治疗靶点
本研究通过转录组学分析探讨补中消饮(BZXD)治疗类风湿关节炎(RA)的机制。在胶原诱导性关节炎(CIA)大鼠模型中,BZXD可有效逆转骨侵蚀,并反向调控33个lncRNA和107个mRNA。差异表达基因主要参与免疫应答、ECM受体相互作用、MAPK信号通路等,筛选出4个lncRNA和3个mRNA作为潜在治疗靶点,体外实验验证了其中两个lncRNA的功能。
要点
- BZXD能有效逆转CIA大鼠的骨侵蚀。
- BZXD反向调控33个lncRNA和107个mRNA。
- 筛选出4个lncRNA和3个mRNA作为潜在靶点。
核心结论
- BZXD通过调控lncRNA和mRNA表达逆转CIA大鼠骨侵蚀,为治疗RA提供机制依据。
研究设计与样本
- 采用CIA大鼠模型,设Control、CIA和BZXD组,使用Arraystar大鼠lncRNA-mRNA芯片技术检测表达谱。
主要发现
- BZXD治疗后,33个lncRNA和107个mRNA差异表达基因被反向调控。
- 差异表达lncRNA主要参与免疫应答,并与ECM受体相互作用、MAPK信号通路等密切相关。
- 鉴定出4个lncRNA(uc.361-、ENSRNOT00000092834、ENSRNOT00000089244、ENSRNOT00000084631)和3个mRNA(Acvr2a、Cbx2、Morc4)作为潜在治疗靶点,其芯片数据与RT-qPCR一致。
- 体外实验证实,沉默lncRNA ENSRNOT00000092834和ENSRNOT00000084631可逆转靶mRNA的表达。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bi Zhong Xiao decoction (BZXD), a traditional Chinese herbal formula, has been used clinically for many years to treat rheumatoid arthritis (RA). Both clinical and experimental studies have revealed that BZXD is effective in treating RA, but the mechanism remains unclear. In this study, we aimed to explore the mechanism of efficacy of BZXD through transcriptomic analysis of lncRNA and mRNA. METHODS: The combination method of ultra-high performance liquid chromatography-mass spectrometry/mass spectrometry was used to assess the quality of BZXD. The efficacy of BZXD in treating collagen-induced arthritis (CIA) was evaluated by clinical assessment, weight changes, hematoxylin-eosin and safranin o-fast green staining, and Micro-CT. Arraystar rat lncRNA-mRNA chip technology was used to determine the lncRNA and mRNA expression profiles of the Control, CIA and BZXD groups, and to screen gene expression profiles related to the curative effect of BZXD. A lncRNA-mRNA co-expression network was constructed for the therapeutic efficacy genes. Through GO function and KEGG pathway enrichment analysis, the biological functions and signaling pathways of therapeutic efficacy genes were determined. Based on fold change and functional annotation, key differentially expressed lncRNAs and mRNAs were selected for reverse transcription-quantitative polymerase chain reaction (RT-qPCR) validation. The functions of lncRNAs targeting mRNAs were verified in vitro. RESULTS: We demonstrated that BZXD could effectively reverse bone erosion. After BZXD treatment, up to 33 lncRNAs and 107 mRNAs differentially expressed genes were reversely regulated by BZXD. These differentially expressed lncRNAs are mainly involved in the biological process of the immune response and are closely related to the ECM-receptor interaction, MAPK signaling pathway, Focal adhesion, Ras signaling pathway, Antigen processing and presentation, and Chemokine signaling pathway. We identified four lncRNAs (uc.361-, ENSRNOT00000092834, ENSRNOT00000089244, ENSRNOT00000084631) and three mRNAs (Acvr2a, Cbx2, Morc4) as potential therapeutic targets for BZXD and their microarray data consistent with the RT-qPCR. In vitro experiments confirmed that silencing the lncRNAs ENSRNOT00000092834 and ENSRNOT00000084631 reversed the expression of target mRNAs. CONCLUSIONS: This study elucidates the possible mechanism of BZXD reversing bone erosion in CIA rats from the perspective of lncRNA and mRNA. To provide a basis and direction for further exploration of the mechanism of BZXD in treating RA.
引用
- He C, Wang Y, Wen Y, et al. An intersectional analysis of LncRNAs and mRNAs reveals the potential therapeutic targets of Bi Zhong Xiao Decoction in collagen-induced arthritis rats. Chin Med. 2022. PMID: 36109779. doi:10.1186/s13020-022-00670-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。